Leopoldo Baiza Durán, MD
Laboratorios Sophia S.A de C.V.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Leopoldo Baiza Durán, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:37 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT04111965 · Clinical Trial to Compare the Safety and Efficacy of Nanodrop®Laboratorios Sophia S.A de C.V. · completed · Dry Eye · study director
- Ph1NCT04081610 · Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic SolutionLaboratorios Sophia S.A de C.V. · completed · Dry Eye · study director
- Ph1NCT03966365 · Safety and Tolerability of the Preservative-free Ophthalmic Solution PRO-122 Compared With Krytantek Ofteno®Laboratorios Sophia S.A de C.V. · completed · Glaucoma · study director
- Ph1NCT03965052 · Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®Laboratorios Sophia S.A de C.V. · completed · Glaucoma · study director
- Ph1NCT03697876 · Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime GelLaboratorios Sophia S.A de C.V. · completed · Dry Eye Syndromes · study director
- Ph3NCT03696342 · Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.Laboratorios Sophia S.A de C.V. · terminated · Conjunctivitis, Bacterial · study director
- Ph3NCT03693989 · Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After PhacoemulsificationLaboratorios Sophia S.A de C.V. · completed · Cataract · study director
- Ph1NCT03524157 · Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy SubjectsLaboratorios Sophia S.A de C.V. · completed · Dry Eye Syndromes, Lubricant Allergy, Tear Disorder · study director
- Ph4NCT03521791 · Efficacy and Safety of PRO-155 on Inflammation of the Conjunctival Surface in Subjects With Grade I-III Pterygium vs Placebo.Laboratorios Sophia S.A de C.V. · completed · Pterygium, Ocular Pain, Ocular Inflammation · study director
- Ph1NCT03519516 · Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy SubjectsLaboratorios Sophia S.A de C.V. · completed · Conjunctivitis, Conjunctivitis, Bacterial · study director
- Ph1NCT03520348 · Safety and Tolerability of the Ophthalmic Gel PRO-167 Versus Corneregel® on Healthy Subjects.Laboratorios Sophia S.A de C.V. · completed · Dry Eye, Dry Eye Syndrome of Unspecified Lacrimal Gland · study director
- Ph3NCT02801617 · Non-inferiority of PRO-067 Ophthalmic Solution vs GAAP Ofteno® in Glaucoma or Ocular HypertensionLaboratorios Sophia S.A de C.V. · terminated · Primary Open Angle Glaucoma, Ocular Hypertension · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:37 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.